exenatide SR two week formulation (PT302) / Peptron  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
exenatide SR two week formulation (PT302) / Peptron
NCT00964262: A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide

Completed
1
34
RoW
SR Exenatide (PT302), Placebo
Peptron, Inc.
Type 2 Diabetes Mellitus
10/10
10/10

Download Options